This content is in French.
A new drug candidate for thyroid cancer
5 mars 2024
The thyroid stimulating hormone receptor (TSHR) could be a selective target for the treatment of thyroid cancer. In this study, researchers report the discovery of a novel orally-administerable TSHR…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Rhitajit Sarkar et al. An Orally Efficacious Thyrotropin Receptor Ligand Inhibits Growth and Metastatic Activity of Thyroid Cancers. J Clin Endocrinol Metab. 2024 Feb 29:dgae114.
View the source
